|
1
| Ad26.ENV.01 | Crucell Holland BV | SEP 2010 |
|
|
2
| Ad5 HIV-1 gag vaccine and MRKAd5 HIV-1 gag vaccine | Merck & Co. | JUN 2007 |
|
|
3
| Ad5HVR48.ENVA.01 | Crucell Holland | APR 2008 |
|
|
4
| GEO-DO3 Vaccine and MVA-HIV62B Vaccine | GeoVax | DEC 2011 |
|
|
5
| HIV Subtype B and Subtype C gp140 | Novartis | JUN 2010 |
|
|
6
| HIV-1 Plasmid DNA Vaccine, pGA2/JS7and MVA HIV62 (Combined IB) | GeoVax | MAY 2010 |
|
|
7
| HIV-1Multiantigen pDNA Vaccine and Human IL-12 pDNA | Profectus | May 2011 |
|
|
8
| MF59C.1 Adjuvant | Novartis | JUN 2011 |
|
|
9
| MRCKAD5HIV-1 GAG/POL/NEF | Merck & Co. | JUN-2007 |
|
|
10
| MVA-CMDR | Walter Reed Army Institute Research (WRAIR) | OCT 2010 |
|
|
11
| PENNVAX-G | Inovio Biomedical Corporation | JUN 2010 |
|
|
12
| rHPIV3cp45 | RCHSPB, NIAID, NIH | OCT 2010 |
|
|
13
| Rotavirus Vaccine (RotaTeq) | Merck | SEP 2011 |
|
|
14
| SAAVI DNA-C2 and SAAVI MVA-C | NIAID/SAAVI | JUN 2010 |
|
|
15
| VRC-HIVADV014-00-VP (Multiclade rAd5 HIV-1 Vaccine) and rAd5 component vaccines | VRC/NIAID/NIH | AUG 2009 |
|
|
16
| VRC-HIVADV014-00-VP and VRC-HIVDNA016-00-VP Combination | VRC/NIAID/NIH | JAN 2009 |
|
|
17
| VRC-HIVADV027-00-VP (Recombinant Adenoviral Serotype 35) | VRC/NIAID/NIH | SEP 2009 |
|
|
18
| VSVIN HIV-1gag Vaccine | Profectus | OCT 2011 |
|